Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii

Current Topics in Microbiology and Immunology

Volumn 219, Issue , 1996, Pages 235-245

  Gross, U ^a   Pohl, F ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; HYDROXYNAPHTHOQUINONE DERIVATIVE; MACROLIDE; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; CELL CULTURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; IN VITRO STUDY; NONHUMAN; PARASITE DEVELOPMENT; PRIORITY JOURNAL; REVIEW; TOXOPLASMA GONDII; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 0029741131     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-51014-4_21     Document Type: Review

References (39)

1. Araujo FG, Shepard RM, Remington JS (1991) In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii. Eur J Clin Microbiol Infect Dis 10:519-524
2. Araujo, FG, Huskinson-Mark J, Guttendge WE, Remington JS (1992a) In vitro and in vivo activities of the hydroxynaphoquinone 566C80 against the cyst form of Toxoplasma gondii Antimicrob Agents Chemother 36:326-330
3. Araujo FG, Prokocimer P, Lin T, Remington JS (1992b) Activity of clarithromycin alone or in combination with other drugs for treatment of murine toxoplasmosis. Antimicrob Agents Chemother 36:2454-2457
4. Beckers CJ, Roos DS, Donald RG, Luft BJ, Schwab JC, Cao Y, Joiner KA (1995) Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics. J Clin Invest 95 367-376
5. Blais J, Garneau V, Chamberland S (1993a) Inhibition of Toxoplasma gondii protein synthesis by azithromycin. Antimicrob Agents Chemother 37:1701-1703
6. Blais J, Tardif C, Chamberland S (1993b) Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii Antimicrob Agents Chemother 37:2571-2577
7. Bohne W, Heesemann J, Gross U (1993) Induction of bradyzoite-specific Toxoplasma gondii antigens in gamma interferon-treated mouse macrophages. Infect Immun 61:1141-1145
8. Bohne W, Heesemann J, Gross U (1994) Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens.a possible role for nitric oxide in triggering stage conversion Infect Immun 62.1761-1767
9. Cantin L, Chamberland S (1993) In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. Antimicrob Agents Chemother 37:1993-1996
10. Chamberland S, Kirst HA, Current WL (1991) Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay. Antimicrob Agents Chemother 35:903-909
11. Chang HR, Pechère JC (1988) In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin (CP-62, 993), and (A-56268) on Toxoplasma gondii Antimicrob Agents Chemother 32:524-529
12. Chang HR, Comte R, Pechère JC (1990) In vitro and in vivo effects of doxycycline on Toxoplasma gondii. Antimicrob Agents Chemother 34:775-780
13. Derouin F, Chastang C (1989) In vitro effects of folate inhibitors on Toxoplasma gondii Antimicrob Agents Chemother 33:1753-1759
14. Derouin F, Chastang C (1990) Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine. J Antimicrob Chemother 25:708-711
15. Derouin F, Nalpas J, Chastang C (1988) Mesure in vitro de l'effet inhibiteur de macrolides, lincosamides et synergestines sur la croissance de Toxoplasma gondii. Path Biol 36 1204-1210.
16. Derouin F, Caroff B, Chau F, Prokocimer P, Pocidalo JJ (1992) Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrob Agents Chemother 36:2852-2855
17. Ferguson DJP, Huskinson-Mark J, Araujo FG, Remington JS (1994) An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii Int J Exp Path 75 111-116
18. Fichera ME, Bhopale MK, Roos DS (1995) In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii Antimicrob Agents Chemother 39:1530-1537
19. Gross U, Bohne W (1994) Toxoplasma gondii strain- and host cell dependent induction of stage conversion. J Euk Microbiol 41:10S-11S
20. Gross U, Bohne W, Soête M, Dubremetz JF (1996) Developmental differentiation between tachyzoites and bradyzoites of Toxoplasma gondii. Parasitol Today 12:30-33
21. Haverkos HW (1987) Assessment of therapy for toxoplasma encephalitis. Am J Med 82:907-914
22. Holfels E, McAuley J, Mack D, Milhous WK, McLeod R (1994) In vitro effects of artemisinin ether, cycloguanil hydrochloride (alone and in combination with sulfadiazine), quinine sulfate, mefloquine, primaquine phosphate, trifluoperazine hydrochloride, and verapamil on Toxoplasma gondii. Antimicrob Agents Chemother 38:1392-1396
23. Hudson AT (1993) Atovaquone - a novel broad-spectrum anti-infective drug. Parasitol Today 9 66-69
24. Huskinson-Mark J, Araujo FG, Remington JS (1991) Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii. J Infect Dis 164:170-177
25. Joss AWL (1992) Treatment. In .Ho-Yen DO, Joss AWL (eds) Human toxoplasmosis Oxford University Press, Oxford, pp 119-143
26. Lindsay DS, Blagburn BL, Hall JE, Tidwell RR (1991) Activity of pentamidine and pentamidine analogs against Toxoplasma gondii in cell cultures Antimicrob Agents Chemother 35:1914-1916
27. Mack DG, McLeod R (1984) New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole, and cyclosporin A. Antimicrob Agents Chemother 26:26-30
28. Parmley SF, Gross U, Sucharczuk A, Windeck T, Sgarlato GD, Remington JS (1994) Two alleles of the gene encoding surface antigen P22 in 25 strains of Toxoplasma gondii J Parasitol 80:293-301
29. Pfefferkorn ER (1978) Toxoplasma gondii the enzymatic defect of a mutant resistant to 5-fluorodeoxyuridine. Exp Parasitol 44:26-35
30. Pfefferkorn ER, Borotz SE (1994) Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin Antimicrob Agents Chemother 38:31-37
31. Pfefferkorn ER, Nothnagel RF, Borotz SE (1992) Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug-resistant mutant Antimicrob Agents Chemother 36:1091-1096
32. Pfefferkorn ER, Borotz SE, Nothnagel RF (1993) Mutants of Toxoplasma gondii resistant to atovaquone (566C80) or decoquinate J Parasitol 79.559-564
33. Piketty C, Derouin F, Rouveix B, Pocidalo JJ (1990) In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice Antimicrob Agents Chemother 34:1467-1472
34. Romand S, Pudney M, Derouin F. (1993) In vitro and in vivo activities of the hydroxynaphthoquinone atovaquone alone or combined with pyrimethamine, sulfadiazine, clarithromycin, or minocycline against Toxoplasma gondii. Antimicrob Agents Chemother 37:2371-2378
35. Sartorius C, Franklin RM (1991) The use of antisense oligonucleotides as chemotherapeutic agents for parasites. Parasitol Today 7:90-94
36. Schoondermark-van de Ven E, Melchers W, Camps W, Eskes T, Meuwissen J, Galama J (1994) Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother 38:1930-1936
37. Schoondermark-van de Ven E, Galama J, Vree T, Camps W, Baars I, Eskes T, Meuwissen J, Meichers W (1995) Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine Antimicrob Agents Chemother 39:137-144
38. Soête M, Camus D, Dubremetz JF (1994) Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp Parasitol 78 361-370
39. Tabbara KF, O'Connor GR (1980) Treatment of ocular toxoplasmosis with clindamycin and sulfadiazine Ophthalmology 87.129-134